Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2014; 4(10): 088-091


Evaluation of Anti-Bacterial, Analgesic and Anti-Inflammatory activities of Oncocalyxone A isolated from Prenanthes sarmentosus

Sivagnanam Ilayaraja, Kalaivanan Prabakaran, Rajamanickam Manivannan.




Abstract

The aim of the present study was to evaluate the anti-bacterial, analgesic and anti-inflammatory activities with oncocalyxone A isolated from the leaves of Prenanthes sarmentosus. The anti-bacterial activity of different concentrations of oncocalyxone A (100, 200 mg) was evaluated against four bacterial species, namely Staphylococcus aurous, Escherichia coli, Aspergillus niger and Aspergillus flavus. Escherichia coli showed the highest susceptibility to this compound. The oral dose of oncocalyxone A at a 200mg/kg exhibited analgesic and anti-inflammatory activities in comparison with standard drug Morphine sulphate at a dose of 5 mg/kg and Diclofenac sodium at a dose of 100 mg/kg respectively. The methanolic extract of Prenanthes sarmentosus, exhibited a weak anti-bacterial, analgesic and anti-inflammatory activities in comparison with isolated oncocalyxone A. The oncocalyxone A at dose of 200mg/kg showed highly significant activities as compared to standard drugs.

Key words: Key Words: oncocalyxone A, Prenanthes sarmentosus, anti-bacterial, analgesic activity, anti-inflammatory activity.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.